ArticleClinical pharmacology and therapeutics2026
Cardiovascular Safety of Febuxostat vs. Allopurinol in Gout Patients with Cardiovascular Diseases: A Target Trial Emulation.
Xiuwen Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.